Protect Your Portfolio With GlaxoSmithKline plc, Pearson plc & Jardine Lloyd Thompson Group plc

GlaxoSmithKline plc (LON:GSK), Pearson plc (LON:PSON) & Jardine Lloyd Thompson Group plc (LON:JLT): Should you include these low beta shares in your investment portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2016 has started off as one of the most volatile years for stock market investors. The FTSE 100 has fallen by 3.9% since the end of 2015, but trading has been choppy. With the large-cap share index having fallen to a 3-year low of 5,500 points earlier this month, the index has since bounced back to just over 6,000 points.

Investors will probably need to protect themselves against further volatility in the rest of the year, as uncertainty about global economic growth continues to increase. Weak export data from numerous countries, slowing consumer spending and worldwide financial volatility all point towards slowing growth. And having considered these downside risks, the OECD today lowered its expectation for global growth in 2016 to 3.0%, down from the 3.3% it predicted in November.

Buying low beta shares is one method of reducing the sensitivity of your portfolio to general market volatility. “Beta” is a measure of how sensitive a particular share is to changes in the market as a whole, so low beta shares should provide stability during those turbulent times.

The following three shares have a five-year beta of less than 0.5, which means these shares have historically risen/(fallen) on average by less than 0.5% with every 1% gain/(decline) in the FTSE All-Share Index, the most-inclusive popular UK equity index. To determine whether they are worth investing in, I shall now look at each in greater detail.

Attractive income

GlaxoSmithKline (LSE: GSK) has recently seen big declines in its profits, as the patent expiry of a few blockbuster drugs has exposed the company to intense pressure from generic drug-makers. 2015 marked a new low point for the company, with annual core earnings per share declining for the sixth consecutive year, after falling 15%, to 75.7p in 2015.

Despite this, the company maintains a strong competitive position in the respiratory, vaccines, HIV and consumer healthcare markets. In addition, it has a strong development pipeline, with up to 20 new treatments seeking regulatory approval by 2020. Glaxo has already launched seven major new drugs in recent months, and looking forward, these new products could potentially bring in more than £4 billion in additional annual sales.

Shares in Glaxo seem a little expensive on an earnings basis, as they trade at 16.9 times its expected 2016 earnings, but they are very attractive from an income standpoint. Glaxo currently yields 5.8%, and analysts expects its forward dividend yield will rise to 6.1% by the following year.

Slowing growth

Pearson‘s (LSE: PSON) shares have been heavily sold off in recent months, as investors have begun to fret about the company’s slowing growth outlook. For 2016, management expects to generate adjusted operating profits of between £580 million and £620 million, which represents a fall of around 13% on its expected 2015 level. Adjusted EPS is expected to decline to between 50p and 55p this year, which gives its shares a forward P/E of 15.2 at the mid-point.

Although, the near term outlook for the company is gloomy, the longer term outlook remains broadly intact. The company’s competitive position is strong, and cyclical factors have been largely to blame for its recent weakness. A fall in US college enrolment had hurt sales and new product launches raised costs, but these impacts should only be temporary. The market for education remains a big growth opportunity.

Recovery forecast

A weaker insurance rating environment is set to cause earnings at Jardine Lloyd Thompson (LSE: JLT) to decline for the first time since 2011. Underlying EPS for the insurance broker is expected to have fallen 11% in 2015, to 51.7p, because of increased investment in its US business and weakness in its UK employee benefits business due to recent government changes to UK pension rules.

However, the company is forecast to make a recovery in the following year, with analysts expecting underlying EPS to rebound by 13%, to 58.3p. This gives shares in Jardine a very reasonable valuation of 13.5 times its expected 2016 earnings. What’s more, its shares have a prospective dividend yield of 4.1%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK owns shares of Jardine Lloyd Thompson. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »